<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T20:43:40Z</responseDate>
  <request identifier="oai:figshare.com:article/34047661" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34047661</identifier>
        <datestamp>2026-10-01T17:26:25Z</datestamp>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_811</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;BRAF mutation frequency by tumor location (proximal colon, distal colon, rectum) in EOCRC vs LOCRC.&lt;/p&gt;</dc:title>
          <dc:creator>Elif Sertesen Çamöz (25157677)</dc:creator>
          <dc:creator>Osman Bilge Kaya (24267303)</dc:creator>
          <dc:creator>Hakan Erçelebi (25157680)</dc:creator>
          <dc:creator>Cengiz Karaçin (25157683)</dc:creator>
          <dc:creator>Yunus Kasım Terzi (25157686)</dc:creator>
          <dc:creator>Zerrin Yılmaz Çelik (25157689)</dc:creator>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Mathematical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>strong independent predictor</dc:subject>
          <dc:subject>significantly less frequent</dc:subject>
          <dc:subject>several prior studies</dc:subject>
          <dc:subject>onset colorectal cancer</dc:subject>
          <dc:subject>multivariate cox regression</dc:subject>
          <dc:subject>least partially explained</dc:subject>
          <dc:subject>cancer genome atlas</dc:subject>
          <dc:subject>meier overall survival</dc:subject>
          <dc:subject>somatic mutation frequencies</dc:subject>
          <dc:subject>braf v600e specifically</dc:subject>
          <dc:subject>meier median os</dc:subject>
          <dc:subject>braf mutation frequency</dc:subject>
          <dc:subject>tumor location attenuated</dc:subject>
          <dc:subject>specific multivariate model</dc:subject>
          <dc:subject>254 crc patients</dc:subject>
          <dc:subject>crc prognostic biomarkers</dc:subject>
          <dc:subject>braf mutation depletion</dc:subject>
          <dc:subject>tumor location adjustment</dc:subject>
          <dc:subject>sample type adjustment</dc:subject>
          <dc:subject>eocrc ), defined</dc:subject>
          <dc:subject>validation cohort ).</dc:subject>
          <dc:subject>tcga pancancer atlas</dc:subject>
          <dc:subject>xlink "&gt; early</dc:subject>
          <dc:subject>001 ), nras</dc:subject>
          <dc:subject>impact cohort adjusted</dc:subject>
          <dc:subject>somatic mutation</dc:subject>
          <dc:subject>pancancer atlas</dc:subject>
          <dc:subject>tumor location</dc:subject>
          <dc:subject>validation cohort</dc:subject>
          <dc:subject>prognostic biomarkers</dc:subject>
          <dc:subject>overall cohort</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>sample type</dc:subject>
          <dc:subject>crc diagnosed</dc:subject>
          <dc:subject>009 ),</dc:subject>
          <dc:subject>braf depletion</dc:subject>
          <dc:subject>001 ).</dc:subject>
          <dc:subject>tumor stage</dc:subject>
          <dc:subject>prognostic implications</dc:subject>
          <dc:subject>independently prognostic</dc:subject>
          <dc:subject>impact cohort</dc:subject>
          <dc:subject>discovery cohort</dc:subject>
          <dc:description>&lt;p&gt;Left: TCGA. Right: MSK-IMPACT. Within-location BRAF differences are substantially smaller than unstratified comparisons, indicating that BRAF-EOCRC associations are at least partially explained by differential tumor location distribution.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T17:26:21Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0359094.g002</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_BRAF_mutation_frequency_by_tumor_location_proximal_colon_distal_colon_rectum_in_EOCRC_vs_LOCRC_p_/34047661</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
